Tue, March 4, 2025
Mon, March 3, 2025
Sun, March 2, 2025
Sat, March 1, 2025
Fri, February 28, 2025
Sun, February 23, 2025
Sat, February 22, 2025
Fri, February 21, 2025
[ Fri, Feb 21st ] - Wired
The Ozempic Shortage Is Over
Thu, February 20, 2025
Wed, February 19, 2025
Tue, February 18, 2025
[ Tue, Feb 18th ] - Politico
Culling the AI workforce
Mon, February 17, 2025

The Ozempic Shortage Is Over


//science-technology.news-articles.net/content/2025/02/21/the-ozempic-shortage-is-over.html
Published in Science and Technology on by Wired   Print publication without navigation

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

The article from WIRED discusses the end of the semaglutide shortage, a drug used in medications like Ozempic and Wegovy for managing type 2 diabetes and aiding weight loss. Initially, there was a significant shortage due to overwhelming demand, particularly for its off-label use in weight loss, which led to supply issues for diabetic patients. The shortage was exacerbated by manufacturing delays and the drug's popularity on social media. However, as of the latest updates, the supply has stabilized, with manufacturers like Novo Nordisk reporting improved availability. The article also touches on the broader implications of this drug's popularity, including the ethical considerations of using it for cosmetic weight loss versus medical necessity, and the potential for new treatments in the pipeline that could offer similar benefits without the current limitations.

Read the Full Wired Article at:
[ https://www.wired.com/story/end-of-semaglutide-shortage-glp1-ozempic-wegovy/ ]

Publication Contributing Sources